Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Mar-Apr;24(2):82-6.
doi: 10.1080/08820530902800322.

Emerging treatments for retinopathy of prematurity

Iason S Mantagos  1 , Deborah K Vanderveen, Lois E H Smith
Affiliations
Review

Emerging treatments for retinopathy of prematurity

Iason S Mantagos et al. Semin Ophthalmol. 2009 Mar-Apr.

Abstract

Retinopathy or prematurity (ROP) is a leading cause of potentially preventable blindness in children. With increased survival of infants born at earlier gestational ages the number of infants at risk from vision loss from ROP has increased. Current treatments consist of close monitoring of oxygen saturation levels, peripheral retinal ablation by cryotherapy or laser photocoagulation, and vitreoretinal surgery. Research in the area of angiogenesis has lead to numerous breakthroughs. Emerging treatments for ROP are targeting the Vascular Endothelial Growth Factor (VEGF) and Insulin-Like Growth Factor 1 (IGF-1) pathways, as well as dietary supplementation with omega-3-polyunsaturated fatty acids.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Terry TL. Retrolental fibroplasia in the premature infant: V. Further studies on fibroplastic overgrowth of the persistent tunica vasculosa lentis. Tran Am Ophthalmol Soc. 1944;44:383–396. - PMC - PubMed
    1. Lutty GA, Chan-Ling T, Phelps DL, et al. Proceedings of the third international symposium on retinopathy of prematurity: An update on ROP from the lab to the nursery (November 2003, Anaheim, California) Mol Vis. 2006;12:532–580. - PubMed
    1. Smith LE. Pathogenesis of retinopathy of prematurity. Semin Neonatol. 2003;8:469–473. - PubMed
    1. Tasman W, Patz A, McNamara JA, et al. Retinopathy of prematurity: The life of lifetime disease. Am J Ophthalmol. 2006;141:167–174. - PubMed
    1. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; A clinical approach. Med J Aust. 1951;2:48–50. - PubMed

MeSH terms

Substances

LinkOut - more resources